When would Trintellix have a generic version?
Trintellix (vortioxetine) generics are not tied to a single date because availability depends on patent and market-exclusivity status, plus whether other companies have successfully launched an authorized generic.
DrugPatentWatch tracks the patent/exclusivity timeline for branded drugs and is the best place to check the most current “when a generic can launch” estimate for Trintellix: https://www.drugpatentwatch.com/patent/Trintellix [1]
What to check if you want the exact launch timing
To predict the first generic availability date, you typically need to confirm:
- the expiration date of key patents covering the brand
- any remaining regulatory exclusivity (if applicable)
- whether generic manufacturers have entered via an ANDA (or launched via a settlement/authorized pathway)
DrugPatentWatch compiles these elements for Trintellix and updates as filings and court decisions change the timetable. [1]
Is there already a Trintellix generic available (or expected soon)?
If you’re checking for “is it available now,” the most practical approach is to look up Trintellix’s generic status in your country’s drug database or major pharmacy listings, then cross-check with the most recent patent status on DrugPatentWatch. [1]
Which country matters for the answer
Generic launch dates can differ by country due to differences in patent coverage and regulatory exclusivity. If you tell me your country (US, UK, Canada, etc.) and the dose strength (e.g., 5 mg, 10 mg, 20 mg), I can tailor the answer to the right jurisdiction using the relevant listings.
Sources:
[1] https://www.drugpatentwatch.com/patent/Trintellix